AstraZeneca, in partnership with the Moi Teaching & Referral Hospital (MTRH), has launched an advanced molecular testing ...
More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows.
Biofidelity, a leader in innovative genomic solutions, today announced the launch of Aspyre Clinical Test for Lung for liquid biopsy samples. Aspyre Clinical Test for Lung analyzes all ...
In the past five years, the lung cancer survival rate has improved 26%, according to the report. It credits deployment of ...
Until the early 2000s, advanced or metastatic non–small cell lung cancer (NSCLC ... the treatment of NSCLC tumors with specific oncogene drivers or molecular alterations. Molecular testing has become ...
Cedar Rapids KCRG-TV on MSN2d
Iowa among worst in nation for new lung cancer casesThe American Lung Association released its 2024 “State of Lung Cancer” report. Lung cancer is the leading cause of cancer ...
The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung Cancer (IASLC) today ...
[Courtesy] Moi Teaching and Referral Hospital in partnership with AstraZeneca has launched an advanced molecular testing platform to enhance lung cancer diagnostics across the country. The ...
MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback